Is Bamlanivimab effective in the treatment of COVID-19?


A: Currently, the evidence is not yet clear, and we need lots more data. The FDA issued an Emergency Use Authorization (EUA) for bamlanivimab use in non-hospitalized patients with mild to moderate COVID-19 on November 9th. Bamlanivimab is a neutralizing monoclonal antibody that targets the spike protein on the SARS-CoV-2 virus. The goal of neutralizing

How is it possible that my friends are social distancing and yet have colds??

Infection and Spread Uncertainty and Misinformation

A: The interventions we use to reduce COVID-19 transmission–such as wearing masks, improving ventilation, and keeping physical distance from other people–don’t target the common cold as well. Unlike the virus that causes COVID-19, which is transmitted through sharing air with infected people, most of the many viruses that cause the common cold–called rhinoviruses–love to hang